Market closed· · CNY · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Recent developments in the AI chip sector include a notable collaboration between VERAXA Biotech and Ardigen. This partnership focuses on integrating artificial intelligence into drug discovery processes to enhance VERAXA's BiTAC pipeline, targeting cancer treatments. The AI will aid in selecting synergistic cancer target pairs, potentially improving therapeutic outcomes by reducing toxicity and systemic effects. This initiative highlights the growing role of AI chips in revolutionizing...
It could be a very good deal for Biwin if NAND prices continue to rise.
Biwin signs a 24-months supply agreement with an unknown NAND maker to get memory worth $1.86 billion.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.